Publication | Open Access

Molecular analysis of the BCR-ABL1 kinase domain in chronic-phase chronic myelogenous leukemia treated with tyrosine kinase inhibitors in practice: Study by the Nagasaki CML Study Group

Hematological MalignancyMedicineReceptor Tyrosine KinaseMolecular AnalysisHematologyMyeloid NeoplasiaTyrosine Kinase InhibitorsBcr-abl1 Kinase DomainRadiation OncologyOncologyCell BiologyCancer ResearchHealth Sciences